An assessment of the role of reactive oxygen species and redox signaling in norepinephrine-induced apoptosis and hypertrophy of H9c2 cardiac myoblasts

Antioxidants and Redox Signaling

Volumn 8, Issue 5-6, 2006, Pages 1081-1092

  Gupta, Manveen K ^a   Neelakantan, T V ^a   Sanghamitra, Mishra ^a   Tyagi, Rakesh K ^a   Dinda, Amit ^b   Maulik, Subir ^b   Mukhopadhyay, Chinmay K ^a   Goswami, Shyamal K ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NORADRENALIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR NRF2;

AGONIST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRAIN; CELL STRAIN H9C2; CONTROLLED STUDY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEART CELL CULTURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HYPERTROPHY; MYOBLAST; NONHUMAN; OXIDATION REDUCTION REACTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TISSUE INDUCTION; UPREGULATION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; APOPTOSIS; CELL LINE; GENES, REPORTER; HYDROGEN PEROXIDE; HYPERTROPHY; MALE; MYOBLASTS, CARDIAC; MYOCARDIUM; NF-E2-RELATED FACTOR 2; NF-KAPPA B; NOREPINEPHRINE; ONCOGENE PROTEINS V-FOS; OXIDANTS; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 33745862737     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.1081     Document Type: Article

References (58)

1. Afzal M, Matsugo S, Sasai M, Xu B, Aoyama K, and Takeuchia T. Method to overcome photoreaction, a serious drawback to the use of dichlorofluorescin in evaluation of reactive oxygen species. Biochem Biophys Res Commun 304: 619-624, 2003.
2. Akazawa H and Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92: 1079-1088, 2003.
3. Barki-Harrington L, Perrino C, and Rockman HA. Network integration of the adrenergic system in cardiac hypertrophy. Cardiovasc Res 63: 391-402, 2004.
4. Booz GW, Day JN, and Baker KM. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol 34: 1443-1453, 2002.
5. Bowie A and O'Neill LA. Oxidative stress and nuclear factor-κB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59: 113-123, 2000.
6. Bueno OF and Molkentin JD. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91: 776-781, 2002.
7. Burch PM, Yuan Z, Loonen A, and Heintz NH. An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry. Mol Cell Biol 24: 4696-4709, 2004.
8. Burkitt MJ and Wardman P. Cytochrome C is a potent catalyst of dichlorofluorescin oxidation: Implications for the role of reactive oxygen species in apoptosis. Biochem Biophys Res Commun 282: 329-333, 2001.
9. Chandel NS, Schumacker PT, and Arch RH. Reactive oxygen species are downstream products of TRAF-mediated signal transduction. J Biol Chem 276: 42728-42736, 2001.
10. Chen LF and Greene WC. Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol 5: 392-401, 2004.
11. Claycomb WC. Culture of cardiac muscle cells in serum-free media. Exp Cell Res 131: 231-236, 1981.
12. Clerk A. The radical balance between life and death. J Mol Cell Cardiol 35: 599-602, 2003.
13. Dangel V, Giray J, Ratge D, and Wisser H. Regulation of beta-adrenoceptor density and mRNA levels in the rat heart cell-line H9c2. Biochem J 317: 925-931, 1996.
14. Eferl R and Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868, 2003.
15. Forman HJ, Fukuto JM, and Torres M. Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am J Physiol Cell Physiol 287: C246-256, 2004.
16. Frantz S, Kelly RA, and Bourcier T. Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J Biol Chem 276: 5197-5203, 2001.
17. Frey N and Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65: 45-79, 2003.
18. Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D, Pouyssegur J, Yaniv M, and Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118: 781-794, 2004.
19. Hess J, Angel P, and Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 117: 5965-5973, 2004.
20. Graham RM, Frazier DP, Thompson JW, Haliko S, Li H, Wasserlauf BJ, Spiga MG, Bishopric NH, and Webster KA. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. J Exp Biol 207: 3189-3200, 2004.
21. Han H, Long H, Wang H, Wang J, Zhang Y, and Wang Z. Progressive apoptotic cell death triggered by transient oxidative insult in H9c2 rat ventricular cells: a novel pattern of apoptosis and the mechanisms. Am J Physiol Heart Circ Physiol 286: H2169-2182, 2004.
22. Hannan RD, Stennard FA, and West A. Expression of c-fos and related genes in the rat heart in response to norepinephrine. J Mol Cell Cardiol 25: 1137-1148, 1993.
23. Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, Karin M, and Kikugawa K. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 22: 3356-3366, 2003.
24. Hendriks BS, Orr G, Wells A, Wiley HS, and Lauffenburger DA. Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells. J Biol Chem 280: 6157-6169, 2005.
25. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, Ueno H, Tada M, and Hori M. Involvement of nuclear factor-κB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105: 509-515, 2002.
26. Huang CY, Kuo WW, Chueh PJ, Tseng CT, Chou MY, and Yang JJ. Transforming growth factor-beta induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK. Biochem Biophys Res Commun 324: 424-431, 2004.
27. Hueber AO. Role of membrane microdomain rafts in TNFR-mediated signal transduction. Cell Death Differ 10: 7-9, 2003.
28. Hur EM and Kim KT. G protein-coupled receptor signaling and cross-talk: achieving rapidity and specificity. Cell Signal 14: 397-405, 2002.
29. Ito K, Hanazawa T, Tomita K, Barnes PJ, and Adcock IM. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun 315: 240-245, 2004.
30. Kamata H, Honda S, M̊aeda S, Chang L, Hirata H, and Karin M. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661, 2005.
31. Kobayashi A, Ohta T, and Yamamoto M. Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. Methods Enzymol 378: 273-286, 2004.
32. Kostin S, Pool L, Elsasser A, Hein S, Drexler HC, Arnon E, Hayakawa Y, Zimmermann R, Bauer E, Klovekorn WP, and Schaper J. Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92: 715-724, 2003.
33. 2 regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol 35: 615-621, 2003.
34. 2. J Mol Cell Cardiol 37: 63-70, 2004.
35. Molavi B and Mehta JL. Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol 19: 488-493, 2004.
36. Molkentin JD. Calcineurin, mitochondrial membrane potential, and cardiomyocyte apoptosis. Circ Res 88: 1220-1222, 2001.
37. Nadal-Ginard B, Kajstura J, Leri A, and Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92: 139-150, 2003.
38. Nguyen T, Yang CS, and Pickett CB. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 37: 433-441, 2004.
39. Ohashi T, Mizutani A, Murakami A, Kojo S, Ishii T, and Taketani S. Rapid oxidation of dichlorodihydrofluorescin with heme and hemoproteins: formation of the fluorescein is independent of the generation of reactive oxygen species. FEBS Lett 511: 21-27, 2002.
40. Olson EN. A decade of discoveries in cardiac biology. Nat Med 10: 467-474, 2004.
41. Pang JJ, Xu RK, Xu XB, Cao JM, Ni C, Zhu WL, Asotra K, Chen MC, and Chen C. Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro. Am J Physiol Heart Circ Physiol 286: H1063-1069, 2004.
42. Rahman I, Marwick J, and Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-κB and proinflammatory gene expression. Biochem Pharmacol 68: 1255-1267, 2000.
43. Remondino A, Kwon SH, Communal C, Pimentel DR, Sawyer DB, Singh K, and Colucci WS. Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 92: 136-138, 2003.
44. Ricci R., Eriksson U., Oudit GY., Eferl R, Akhmedov A, Sumara I, Sumara G, Kassiri Z, David JP, Bakiri L, Sasse B, Idarraga MH, Rath M, Kurz D, Theussl HC, Perriard JC, Backx P, Penninger JM, and Wagner EF. Distinct functions of junD in cardiac hypertrophy and heart failure. Genes Dev 19: 208-213, 2005.
45. Sabri A, Hughie HH, and Lucchesi PA. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal 5: 731-740, 2003.
46. Sharov VG, Todor A, Suzuki G, Morita H, Tanhehco EJ, and Sabbah HN. Hypoxia, angiotensin-II, and norepinephrine mediated apoptosis is stimulus specific in canine failed cardiomyocytes: a role for p38 MAPK, Fas-L and cyclin D1. Eur J Heart Fail 5: 121-129, 2003.
47. Shirsat NV and Shaikh SA. Overexpression of the immediate early gene fra-1 inhibits proliferation, induces apoptosis, and reduces tumourigenicity of c6 glioma cells. Exp Cell Res 291: 91-100, 2003.
48. Stone JR. An assessment of proposed mechanisms for sensing hydrogen peroxide in mammalian systems. Arch Biochem Biophys 422: 119-124, 2004.
49. Sugden PH. Signaling pathways in cardiac myocyte hypertrophy. Ann Med 33: 611-622, 2001.
50. Tell G, Damante G, Caldwell D, and Kelley MR. The intracellular localization of APE1/Ref-1: more than a passive phenomenon. Antioxid Redox Signal 7: 367-384, 2005.
51. Vial E and Marshall CJ. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J Cell Sci 11: 4957-4963, 2003.
52. Vinson C, Myakishev M, Acharya A, Mir AA, Moll JR, and Bonovich M. Classification of human B-ZIP proteins based on dimerization properties. Mol Cell Biol 22: 6321-6335, 2002.
53. 2+/calmodulin kinase signaling pathway. Circ Res 95: 798-806, 2004.
54. Webster KA, Discher DJ, and Bishopric NH. Induction and nuclear accumulation of fos and jun protooncogenes in hypoxic cardiac myocytes. J Biol Chem 268: 16852-16858, 1993.
55. Wellner M, Dechend R, Park JK, Shagdarsuren E, Al Saadi N, Kirsch T, Gratze P, Schneider W, Meiners S, Fiebeler A, Haller H, Luft FC, and Muller DN. Cardiac gene expression profile in rats with terminal heart failure and cachexia. Physiol Genomics 20: 256-267, 2005.
56. Williamson DL, Kimball SR, and Jefferson LS. Acute treatment with TNF-α attenuates insulin-stimulated protein synthesis in cultures of C2C12 myotubes through a MEK1-sensitive mechanism. Am J Physiol Endocrinol Metab 289: E95-104, 2005.
57. Wu S, Tan M, Hu Y, Wang JL, Scheuner D, and Kaufman RJ. Ultraviolet light activates NF-κB through translational inhibition of IκBα synthesis. J Biol Chem 279: 34898-34902, 2004.
58. Yun-Ching F, Ching-Shiang C, Sui-Chu Y, Betau H, Yung-Tsung C, and Shih-Lan H. Norepinephrine induces apoptosis in neonatal rat cardiomyocytes through a reactive oxygen species-TNFα-caspase signaling pathway. Cardiovasc Res 62: 558-567, 2004.